Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William T Dauer

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 28, 2014
Neurogenetic disease: genes, mechanisms, and future promiseWilliam T Dauer
Cell|April 15, 2014
Multiplying messages LRRK beneath Parkinson diseaseWilliam T Dauer, Ming Guo
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2004
Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutationRose E Goodchild, William T Dauer
Cold Spring Harbor Perspectives in Medicine|March 7, 2012
Leucine-rich repeat kinase 2 for beginners: six key questionsLauren R Kett, William T Dauer
Human Molecular Genetics|September 16, 2015
A novel conditional knock-in approach defines molecular and circuit effects of the DYT1 dystonia mutationCorinne E Weisheit, William T Dauer
Movement Disorders : Official Journal of the Movement Disorder Society|September 14, 2016
Endolysosomal dysfunction in Parkinson's disease: Recent developments and future challengesLauren R Kett, William T Dauer
Brain : a Journal of Neurology|April 29, 2014
Magic shotgun for Parkinson's disease?Roger L Albin, William T Dauer
Neurology|June 23, 2012
Parkinson syndrome. Heterogeneity of etiology; heterogeneity of pathogenesis?Roger L Albin, William T Dauer
The Journal of Cell Biology|March 16, 2005
The AAA+ protein torsinA interacts with a conserved domain present in LAP1 and a novel ER proteinRose E Goodchild, William T Dauer
Cell Cycle (Georgetown, Tex.)|March 2, 2010
New messages in the nuclear envelopeWilliam T Dauer, Howard J Worman
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 28, 2014
Neurogenetic disease: genes, mechanisms, and future promiseWilliam T Dauer
Cell|April 15, 2014
Multiplying messages LRRK beneath Parkinson diseaseWilliam T Dauer, Ming Guo
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2004
Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutationRose E Goodchild, William T Dauer
Cold Spring Harbor Perspectives in Medicine|March 7, 2012
Leucine-rich repeat kinase 2 for beginners: six key questionsLauren R Kett, William T Dauer
Human Molecular Genetics|September 16, 2015
A novel conditional knock-in approach defines molecular and circuit effects of the DYT1 dystonia mutationCorinne E Weisheit, William T Dauer
Movement Disorders : Official Journal of the Movement Disorder Society|September 14, 2016
Endolysosomal dysfunction in Parkinson's disease: Recent developments and future challengesLauren R Kett, William T Dauer
Brain : a Journal of Neurology|April 29, 2014
Magic shotgun for Parkinson's disease?Roger L Albin, William T Dauer
Neurology|June 23, 2012
Parkinson syndrome. Heterogeneity of etiology; heterogeneity of pathogenesis?Roger L Albin, William T Dauer
The Journal of Cell Biology|March 16, 2005
The AAA+ protein torsinA interacts with a conserved domain present in LAP1 and a novel ER proteinRose E Goodchild, William T Dauer
Cell Cycle (Georgetown, Tex.)|March 2, 2010
New messages in the nuclear envelopeWilliam T Dauer, Howard J Worman
Pageof 8